These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. O'Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN. Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282 [Abstract] [Full Text] [Related]
11. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. Berger WE, Milgrom H, Chervinsky P, Noonan M, Weinstein SF, Lutsky BN, Staudinger H. Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278 [Abstract] [Full Text] [Related]
12. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K, Noonan M, Silkoff PE, Uryniak T. Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [Abstract] [Full Text] [Related]
15. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Kuna P, Creemers JP, Vondra V, Black PN, Lindqvist A, Nihlen U, Vogelmeier C. Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989 [Abstract] [Full Text] [Related]
16. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma. Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA. Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849 [Abstract] [Full Text] [Related]